Company Happenings
Aardvark Therapeutics Appoints Renowned Biopharma Leaders Roy D. Baynes and Susan E. Graf to its Board of Directors
Aardvark Therapeutics, Inc. (Aardvark), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases,...
Aardvark Therapeutics Expands Management Team with Two Key Hires
SAN DIEGO, Sept. 10, 2024 — Aardvark Therapeutics, Inc., a biopharmaceutical company, announced the appointment of Manasi Sinha Jaiman, M.D., M.P.H. as Chief Medical Officer and Tom Bicsak, Ph.D.,...
Interview with NYSE: Revolutionizing Obesity Treatment with ARD-101
Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, joined Judy Shaw on #NYSEFloorTalk to talk about their innovative obesity drug, ARD-101. He shared how...
Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, interviews on accomplishments with Nasdaq
Nasdaq Listings Host Kristina Ayanian delves into companies’ notable accomplishments, industry trends, and the driving factors behind their success through engaging conversations with C-suite executives...
Aardvark Therapeutics Announces $85 Million Oversubscribed Series C Financing
Biotech execs vie for a share of obesity drug boom: ‘It’s the early innings’
A link to the full article by STAT can be found here.
...